[Diagnosis of resistance in the treatment of AIDS: clarification of viral and cellular factors].
Gröschel
B
B
Institut für Medizinische Virologie, Johann Wolfgang Goethe-Universität Frankfurt/Main. Groeschel@em.uni-frankfurt.de
Spielhofen
A
A
Stürmer
M
M
Cinatl
J
J
Doerr
H W
HW
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000378:metabolism / Q000821:virology; D000818:Animals; D019380:Anti-HIV Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D023241:Antiretroviral Therapy, Highly Active; D018432:Drug Resistance, Multiple; D024882:Drug Resistance, Viral; D005260:Female; D005814:Genes, Viral / Q000235:genetics; D005838:Genotype; D006678:HIV / Q000187:drug effects* / Q000235:genetics* / Q000302:isolation & purification; D017320:HIV Protease Inhibitors / Q000494:pharmacology; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D051379:Mice; D009154:Mutation; D010641:Phenotype; D011247:Pregnancy; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology; D019562:Viral Load
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors